Pharma News, 2018

LONDON (Reuters) - AstraZeneca said on Monday its diabetes drug Farxiga met a key goal in a major clinical study designed to show the heart-protecting benefits of the medicine.

(Reuters) - More than 3 million people died in 2016 due to drinking too much alcohol, meaning one in 20 deaths worldwide was linked to harmful drinking, the World Health Organization (WHO&...

September 2018 marks the seventh World Alzheimer’s Month and today, September 17, Novartis, Amgen and Banner Alzheimer’s Institute, in association with Alzheimer’s Disease International, releas...

Swiss pharmaceutical giant Roche announced it will build an 863 million yuan ($125.

AUSTIN, Texas, Sept.

(Reuters) - A European Medicines Agency panel on Friday recommended the approval of U.

New Jersey-based Cambrex closed on its $425 million acquisition of dosage-form CDMO Halo Pharma and the two manufacturing plants picked up in the deal.

(Reuters Health) - People who live in low-income and middle-income countries may have a harder time finding and affording essential medicines for diabetes than residents of wealthier nations, ...

TOKYO, September 20, 2018  - Astellas Pharma Inc.

LONDON (Reuters) - Europe has approved a fifth copy of AbbVie’s $18-billion-a-year biologic drug Humira – the world’s best-selling prescription medicine – ramping up competition among ...

Allergan and Sosei are voluntarily suspending clinical development activities with HTL0018318 pending investigation of an unexpected toxicology finding in an animal study involving non-human primates.

Physician Peter Gøtzsche, a board member of the organization, has been an outspoken critic of certain vaccines and of the pharma industry in general.